Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering
Top Cited Papers
- 9 May 2008
- journal article
- Published by Elsevier in Biomaterials
- Vol. 29 (22), 3245-3252
- https://doi.org/10.1016/j.biomaterials.2008.04.031
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Effect of Autologous Bone Marrow Stromal Cell Seeding and Bone Morphogenetic Protein-2 Delivery on Ectopic Bone Formation in a Microsphere/Poly(Propylene Fumarate) CompositeTissue Engineering, Part A, 2009
- Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implantsJournal of Controlled Release, 2008
- Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fracturesJournal of Orthopaedic Research, 2006
- Bone-Tissue-Engineering Material Poly(propylene fumarate): Correlation between Molecular Weight, Chain Dimensions, and Physical PropertiesBiomacromolecules, 2006
- Controlled drug release from a novel injectable biodegradable microsphere/scaffold composite based on poly(propylene fumarate)Journal of Biomedical Materials Research Part A, 2006
- Controlled Release from Poly(Lactic-Co-Glycolic Acid) Microspheres Embedded in an Injectable, Biodegradable Scaffold for Bone Tissue EngineeringMaterials Science Forum, 2003
- Experimental osteoinduction by recombinant human bone morphogeneticprotein 2 in tissue with low blood flow: a study in ratsBritish Journal of Oral and Maxillofacial Surgery, 2001
- Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinductionin vivoJournal of Biomedical Materials Research, 1999
- Transforming growth factor‐β1 enhances bone healing to unloaded tricalcium phosphate coated implants: An experimental study in dogsJournal of Orthopaedic Research, 1996
- Interaction of Recombinant Human Bone Morphogenetic Protein-2 with Poly (d,lLactide-co-glycolide) MicrospheresPharmaceutical Development and Technology, 1996